Panna SharmaCEO, President at Lantern Pharma, Inc.
Panna Sharma is the President and Chief Executive Officer of Lantern Pharma Inc. (NASDAQ: LTRN). As CEO, he is responsible for developing Lantern’s strategic vision, working closely with venture investors to raise capital, and placing the company at the forefront of artificial intelligence (AI) and genomics in the development of its pipeline of precision oncology therapies. Prior to joining Lantern in 2018, Sharma was the President and CEO of Cancer Genetics and the Managing Partner and CEO of TSG Partners. He attended Boston University in the University Professors Program and focused his studies on Philosophy of Science, Neural Networks and AI.